aptaTargets 

aptaTargets innovates through aptamer technology

OWNER

David Segarra (See Profile)

Sector

Therapeutics

Stage

Development, market readiness, clinical trial

Country

Spain


Clinical-stage biotech firm specialized in therapeutic aptamers

Treating severe COVID-19 patients by targeting innate immunity

Potent anti-inflammatory effect confirmed in different preclinical models

Excellent safety and kinetics profile (confirmed in Phase 1 trial)

Experienced team, leading products from discovery to patients

This information is confidential, do not share or copy.

Under evaluation at least till: 2nd June

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2020 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar